Featured Article
ANDREA SAMBATI
President and Chief Executive Officer, Boehringer Ingelheim (Canada) Ltd.
"We are actively preparing for a future in which real time data, empowered customers and artificial intelligence will dramatically influence healthcare and accelerate macro innovations."
Benefits

Jeff Boutilier
General Manager, Pharmacy, and Chief Clinical Officer, Express Scripts Canada
“More than 30 new rare disease treatments are on the horizon. That’s great from a treatment standpoint, but these treatments come with extremely high prices that will continue to put a lot of pressure on private drug plan spend.”
Investment

Ted Welter
Managing Director & Chief Investment Officer, Alternative Investments, TD Greystone Asset Management
“Investing in private asset classes is complex, and it is imperative that investment managers are aligned with the long-term needs of institutional clients, especially in a dynamic market. It is a strong foundation that I believe will enable us to continue to be relevant to our clients - now and into the future.”

Regina Chi
Vice-President and Portfolio Manager, Emerging Markets Strategies, AGF Investments Inc.
“We invest in companies that earn a rate of return above their cost of capital and that have long-term sustainable competitive advantages. When we look at a stock, we look for a company surrounded by a strong economic moat.”